4.7 Article

Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome

Journal

ANNALS OF NEUROLOGY
Volume 89, Issue 3, Pages 459-473

Publisher

WILEY
DOI: 10.1002/ana.25965

Keywords

-

Funding

  1. Brain Research Center, National Yang-Ming University
  2. Center for Intelligent Drug Systems and Smart Biodevices (IDS2B) from The Featured Areas Research Center Program by the Ministry of Education (MOE) in Taiwan
  3. Ministry of Science and Technology, Taiwan [MOST-107-2314-B-010-021, 108-2314-B-010 -022 -MY3, MOST 108-2321-B-010-014-MY2, MOST 108-2321-B010-001-, MOST 108-2314-B-010-023-MY3, MOST 108-2633-B-009-001]
  4. Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-211-123001, MOHW 108-TDU-B-211-133001]
  5. Taipei Veterans General Hospital, Taiwan [VGH-106-D9-001-MY2-2, V108C-066]
  6. Warshel Institute for Computational Biology from Shenzhen City and Longgang District
  7. Ganghong Young Scholar Development Fund of Shenzhen Ganghong Group Co., Ltd.

Ask authors/readers for more resources

This study identified a panel of miRNAs that distinguished patients with RCVS from controls, with let-7a-5p, let-7b-5p, and let-7f-5p showing higher abundance in patients with ictal migraine. Target prediction and pathway analysis suggested their involvement in RCVS pathogenesis, which was confirmed in vitro. MiR-130a-3p was associated with disruption of the blood-brain barrier and increased permeability in a human BBB model.
Objective The purpose of this study was to investigate the significance of circulating micro RNAs (miRNAs) in the pathogenesis of reversible cerebral vasoconstriction syndrome (RCVS). Methods We prospectively recruited 3 independent cohorts of patients with RCVS and age-matched and sex-matched controls in a single medical center. Next-generation small RNA sequencing followed by quantitative polymerase chain reaction (PCR) was used to identify and validate differentially expressed miRNAs, which was cross-validated in migraine patients in ictal stage or interictal stage. Computational analysis was used to predict the target genes of miRNAs, followed by in vitro functional analysis. Results We identified a panel of miRNAs including miR-130a-3p, miR-130b-3p, let-7a-5p, let-7b-5p, and let-7f-5p that well differentiated patients with RCVS from controls (area under the receiver operating characteristics curve [AUC] was 0.906, 0.890, and 0.867 in the 3 cohorts, respectively). The abundance of let-7a-5p, let-7b-5p, and let-7f-5p, but not miR-130a-3p nor miR-130b-3p, was significantly higher in patients with ictal migraine compared with that of controls and patients with interictal migraine. Target prediction and pathway enrichment analysis suggested that the transforming growth factor-beta signaling pathway and endothelin-1 responsible for vasomotor control might link these miRNAs to RCVS pathogenesis, which was confirmed in vitro by transfecting miRNAs mimics or incubating the patients' cerebrospinal fluid (CSF) in 3 different vascular endothelial cells. Moreover, miR-130a-3p was associated with imaging-proven disruption of the blood-brain barrier (BBB) in patients with RCVS and its overexpression led to reduced transendothelial electrical resistance (ie, increased permeability) in in vitro human BBB model. Interpretation We identified the circulating miRNA signatures associated with RCVS, which may be functionally linked to its headache, BBB integrity, and vasomotor function. ANN NEUROL 2020

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available